Pharmaceuticals, Biotechnology and Life Sciences
BOSTON, March 02, 2022 (GLOBE NEWSWIRE) — Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK) today announced that the company will host a…
SAN FRANCISCO, March 02, 2022 (GLOBE NEWSWIRE) — Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that the Company will participate…
– Top-line results from PaTHway, a Phase 3 randomized study evaluating the safety, tolerability, and efficacy of TransCon™ PTH in…
SAN DIEGO, March 02, 2022 (GLOBE NEWSWIRE) — Fate Therapeutics, Inc. (the “Company” or “Fate Therapeutics”) (NASDAQ: FATE), a clinical-stage…
NEWS RELEASE – REGULATED INFORMATION2 MARCH 2022, 4:00 PM EST / 22:00 CET MDxHealth Reports Financial Year 2021 Results…
Holders representing approximately 62% of total Debentures extend Forbearance Period until March 14, 2022 to allow negotiations to continueTORONTO, March…
WARREN, N.J., Feb. 28, 2022 (GLOBE NEWSWIRE) — Aquestive Therapeutics, Inc. (NASDAQ: AQST), a pharmaceutical company advancing medicines to solve…
SOUTH SAN FRANCISCO, Calif., Feb. 28, 2022 (GLOBE NEWSWIRE) — In a release issued under the same headline on Monday,…
CHICAGO, Feb. 28, 2022 (GLOBE NEWSWIRE) — Cosmos Holdings, Inc. (“the Company”) (Nasdaq: COSM), an international pharmaceutical company with a…
CAMBRIDGE, Mass., Feb. 28, 2022 (GLOBE NEWSWIRE) — Surface Oncology (Nasdaq: SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that…